135 related articles for article (PubMed ID: 8445212)
1. Simultaneous steroids/interferon therapy in chronic hepatitis B.
Causse X; Godinot H; Chevallier M; Chossegros P; Zoulim F; Zarski JP; Meschiewitz C; Albrecht J; Trépo C
J Hepatol; 1993 Jan; 17(1):128-9. PubMed ID: 8445212
[No Abstract] [Full Text] [Related]
2. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
[TBL] [Abstract][Full Text] [Related]
3. Interferon for hepatitis B: US experience.
Perrillo RP
Gut; 1993; 34(2 Suppl):S95-6. PubMed ID: 8314498
[TBL] [Abstract][Full Text] [Related]
4. Chronic viral hepatitis--benefits of current therapies.
Hoofnagle JH; Lau D
N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
[No Abstract] [Full Text] [Related]
5. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
[TBL] [Abstract][Full Text] [Related]
6. [Results of 2 years of interferon treatment in HBeAg positive chronic hepatitis B].
Hu LH; Long XZ; Tang CL
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):940-1. PubMed ID: 20038338
[No Abstract] [Full Text] [Related]
7. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis B with interferon alfa-2b.
Müller R; Baumgarten R; Markus R; Schulz M; Wittenberg H; Hintsche-Kilger B; Fengler JD; Von Wussow P; Meisel H; Klein H
J Hepatol; 1990; 11 Suppl 1():S137-40. PubMed ID: 2079572
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
[TBL] [Abstract][Full Text] [Related]
10. Persistent hepatitis B virus following interferon alfa therapy and liver transplantation.
Lavine JE; Lake JR; Ascher NL; Ferrell LD; Ganem D; Wright TL
Gastroenterology; 1991 Jan; 100(1):263-7. PubMed ID: 1983831
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha 2b treatment in hepatitis B carriers. Effect on hepatitis B virus DNA levels in children infected with different genotypes.
Sangfelt P; Norder H; Magnius LO; Alaeus A; Carlsson T; Reichard O
Acta Paediatr; 1997 Feb; 86(2):135-7. PubMed ID: 9055880
[TBL] [Abstract][Full Text] [Related]
12. Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection.
Lok AS; Lai CL; Leung EK
Hepatology; 1990 Dec; 12(6):1266-70. PubMed ID: 2258142
[TBL] [Abstract][Full Text] [Related]
13. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.
Lisker-Melman M; Webb D; Di Bisceglie AM; Kassianides C; Martin P; Rustgi V; Waggoner JG; Park Y; Hoofnagle JH
Ann Intern Med; 1989 Sep; 111(6):479-83. PubMed ID: 2774373
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
[TBL] [Abstract][Full Text] [Related]
15. Interferon alfa-2b for chronic hepatitis B.
Herzenberg H
N Engl J Med; 1991 Feb; 324(7):493-4. PubMed ID: 2025320
[No Abstract] [Full Text] [Related]
16. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.
Hoofnagle JH; Peters M; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Hallahan C; Park Y; Meschievitz C; Jones EA
Gastroenterology; 1988 Nov; 95(5):1318-25. PubMed ID: 3049216
[TBL] [Abstract][Full Text] [Related]
17. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
[TBL] [Abstract][Full Text] [Related]
18. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
Craxì A; Di Marco V; Volpes R; Marra S; Rizzetto M; Rosina F; Barbera C; Bortolotti F; Crivellaro C; Iannuzzi C
Prog Clin Biol Res; 1991; 364():399-404. PubMed ID: 2020715
[No Abstract] [Full Text] [Related]
19. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a long-term follow-up study.
Coppens JP; Cornu C; Lens E; Lamy M; Geubel AP
J Hepatol; 1990; 11 Suppl 1():S126-8. PubMed ID: 2079569
[TBL] [Abstract][Full Text] [Related]
20. Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis.
Cohard M; Poynard T; Mathurin P; Zarski JP
Hepatology; 1994 Dec; 20(6):1390-8. PubMed ID: 7527000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
